Several lines of clinical investigation support the hypothesis that facilitated peripheral neurogenic inflammation, involving neuropeptides such as substance P (SP), contributes to some of the signs and symptoms of CRPS [9-12]. Here, TAC1 is linked to complex regional pain syndrome.